The supplemental premarket approval application is supported by Phase III data, which showed significant improvements in neck ...

Under terms of the deal, AbbVie will acquire Capstan’s lead asset, CPTX2309—an in vivo anti-CD19 CAR T-cell therapy in Phase ...

Biljana Naumovic, US President, oncology, solid tumor, Johnson & Johnson Innovative Medicine discusses key takeaways from the ...

Gamifant marks the first-ever FDA-approved treatment for both adult and pediatric patients with hemophagocytic ...

William Shatner endorsed Tinnitus Quest, a nonprofit seeking to promote new treatments and a cure for the condition. Yet, ...

In response to the rising importance of real-world evidence (RWE) in showing value to payers beyond traditional clinical ...